Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. magtest

MAGTEST

MAGTEST: Simple and specific next generation lab-on-a-chip in-vitro molecular diagnostic device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MAGTEST project word cloud

Explore the words cloud of the MAGTEST project. It provides you a very rough idea of what is the project "MAGTEST" about.

deployment    annual    expressed    gland    award    validated    animal    city    dairy    portable    smeinst    compact    efficient    convenient    company    operate    introduction    dna    6bn    2013    investment    innovation    bulky    simply    8    time    pipeline    world    ipr    07    competitiveness    diagnostics    industrialization    cows    resistances    winning    health    mastitis    parallel    margins    accurate    significantly    magnomics    producers    2bn    sustainable    danger    bovine    infection    antibiotics    proprietary    tool    regards    treatments    strategy    worth    solutions    disease    status    platform    fundamental    industrial    crushing    molecular    2017    vitro    line    mammary    alone    biotechnology    antimicrobial    site    market    boost    farms    2018    first    informative    detect    substrate    initially    devastating    commercialization    hindrances    milk    clear    economic    forum    too    bacteria    human    identification    reducing    fast    businesses    kansas    diagnostic    magtest    judicious    industry    either    2016    device    till    detection    2015    bacterial   

Project "MAGTEST" data sheet

The following table provides information about the project.

Coordinator		 MAGNOMICS SA 

Organization address
address: PARQUE TECNOLOGICO DE CANTANHEDE NUCLEO 04 LOTE 2
city: CANTANHEDE
postcode: 3060 197
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Project website http://www.magnomics.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-08-01   to  2017-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAGNOMICS SA PT (CANTANHEDE) coordinator 50˙000.00

Map

 Project objective

Antimicrobial resistances are a clear and present danger for human health. More than ever, it is fundamental to have an accurate and fast bacteria identification tool to ensure the judicious deployment of antibiotics.

Current diagnostic solutions are either too complex and bulky to operate “on site”, or are simply not informative enough. Magnomics novel, fast, award winning proprietary technology is able to detect bacterial DNA using a simple, compact platform. This fully portable, easy to use in-vitro molecular diagnostic device addresses the concerns expressed by the European Commission with regards to antimicrobial resistances: it allows for the easy and convenient detection of bacteria in any substrate, significantly reducing the lead time for treatments.

In line with the expected impact of the “SMEInst-07-2016-2017” topic, Magnomics will initially focus on animal health diagnostics. This choice of market, worth €2.6bn in 2013 with an 8% growth estimated till 2018, was fully validated after winning the Innovation Award at the Kansas City Animal Health Investment Forum in 2015. Addressing a devastating disease in dairy farms across the world that is crushing the margins of milk producers in the EU, the first product will target bovine mastitis, an infection of the mammary gland of dairy cows with an annual economic impact of over €2bn in the EU alone.

This technology is expected to significantly boost the competitiveness of the dairy industry through the reduction of health-related hindrances to production. In parallel, the milk production businesses will become more sustainable through the introduction of a high-end biotechnology process within their industrial pipeline, ensuring the efficient use of resources. MAGTEST will allow the company to fully assess the market potential, IPR status of Magnomics’ technology, ensuring an effective industrialization and commercialization strategy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAGTEST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAGTEST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)

ARMeD_free (2017)

Antibiotic resistance-free meat and dairy products

Read More  

KEEP-IT-UP (2018)

KEEP-IT-UP: Redefining shelf life monitoring in the global food industry with a new intelligent Time-Temperature Indicator for perishable products

Read More  

geoBone (2018)

geoBone: A Unique Mineral Supplement for Bone Health and Prevention of Osteoporosis SustainablyProduced from Geothermal Resources through a Ground-breaking Process.

Read More